These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17564583)

  • 1. Five-year follow-up of waist circumference, insulin and ALT levels in familial combined hyperlipidaemia.
    Brouwers MC; van Greevenbroek MM; Vermeulen VM; van Lin JM; van der Kallen CJ; de Bruin TW
    Clin Sci (Lond); 2007 Nov; 113(9):375-81. PubMed ID: 17564583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abdominal obesity and expression of familial combined hyperlipidemia.
    van der Kallen CJ; Voors-Pette C; de Bruin TW
    Obes Res; 2004 Dec; 12(12):2054-61. PubMed ID: 15687407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year incidence of type 2 diabetes mellitus in patients with familial combined hyperlipidaemia.
    Brouwers MC; van der Kallen CJ; Schaper NC; van Greevenbroek MM; Stehouwer CD
    Neth J Med; 2010 Apr; 68(4):163-7. PubMed ID: 20421657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parabolic relationship between plasma triacylglycerols and LDL-cholesterol in familial combined hyperlipidaemia: the multiple-type hyperlipidaemia explained?
    Brouwers MC; de Graaf J; van Greevenbroek MM; Georgieva AM; van der Kallen CJ; Ter Avest E; Stehouwer CD; Stalenhoef AF; de Bruin TW
    Clin Sci (Lond); 2008 Mar; 114(5):393-401. PubMed ID: 17953518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum adiponectin is decreased in patients with familial combined hyperlipidemia and normolipaemic relatives and is influenced by lipid-lowering treatment.
    Arca M; Cambuli VM; Montali A; Sentinelli F; Filippi E; Campagna F; Quagliarini F; Antonini R; Romeo S; Baroni MG
    Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):660-6. PubMed ID: 19632099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of insulin resistance in familial combined hyperlipidemia.
    Veerkamp MJ; de Graaf J; Stalenhoef AF
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1026-31. PubMed ID: 15731490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults.
    Sung KC; Ryan MC; Kim BS; Cho YK; Kim BI; Reaven GM
    Diabetes Care; 2007 Aug; 30(8):2113-8. PubMed ID: 17475935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of elevated serum alanine aminotransferase with metabolic factors in obese children: sex-related analysis.
    Di Bonito P; Sanguigno E; Di Fraia T; Forziato C; Boccia G; Saitta F; Iardino MR; Capaldo B
    Metabolism; 2009 Mar; 58(3):368-72. PubMed ID: 19217453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased arterial stiffness in familial combined hyperlipidemia.
    Brouwers MC; Reesink KD; van Greevenbroek MM; Meinders JM; van der Kallen CJ; Schaper N; Hoeks AP; Stehouwer CD
    J Hypertens; 2009 May; 27(5):1009-16. PubMed ID: 19402225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty liver is an integral feature of familial combined hyperlipidaemia: relationship with fat distribution and plasma lipids.
    Brouwers MC; Bilderbeek-Beckers MA; Georgieva AM; van der Kallen CJ; van Greevenbroek MM; de Bruin TW
    Clin Sci (Lond); 2007 Jan; 112(2):123-30. PubMed ID: 16958621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia.
    Ayyobi AF; McGladdery SH; McNeely MJ; Austin MA; Motulsky AG; Brunzell JD
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1289-94. PubMed ID: 12750118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk factors in obese women and their first-degree relatives.
    Saraç F; Ozgen AG; Yilmaz C; Tüzün M
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):371-7. PubMed ID: 18065331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study.
    Hopkins PN; Heiss G; Ellison RC; Province MA; Pankow JS; Eckfeldt JH; Hunt SC
    Circulation; 2003 Aug; 108(5):519-23. PubMed ID: 12847072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia.
    ter Avest E; Sniderman AD; Bredie SJ; Wiegman A; Stalenhoef AF; de Graaf J
    Clin Sci (Lond); 2007 Jan; 112(2):131-9. PubMed ID: 17054424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension.
    Hunt SC; Wu LL; Hopkins PN; Stults BM; Kuida H; Ramirez ME; Lalouel JM; Williams RR
    Arteriosclerosis; 1989; 9(3):335-44. PubMed ID: 2497719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of insulin resistance in obese patients on elevated serum alanine aminotransferase.
    De Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R; Gonzalez Hernandez JM
    Eur Rev Med Pharmacol Sci; 2007; 11(1):21-5. PubMed ID: 17405346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
    Yoo J; Lee S; Kim K; Yoo S; Sung E; Yim J
    Diabetes Res Clin Pract; 2008 Sep; 81(3):321-6. PubMed ID: 18571268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma PAI-1 levels are independently related to fatty liver and hypertriglyceridemia in familial combined hyperlipidemia, involvement of apolipoprotein E.
    Brouwers MC; Govers-Riemslag J; Schalkwijk CG; van Greevenbroek MM; van der Kallen CJ; Bekers O; van Dieijen-Visser MP; Ten Oever J; Bilderbeek-Beckers MA; de Bruin TW; Ten Cate H; Stehouwer CD
    Thromb Res; 2008; 122(4):466-72. PubMed ID: 18262228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
    Appel SJ; Harrell JS; Davenport ML
    J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of body fat distribution by waist circumference, dual-energy X-ray absorptiometry and ultrasonography to insulin resistance by homeostasis model assessment and lipid profile in obese and non-obese postmenopausal women.
    dos Santos RE; Aldrighi JM; Lanz JR; Ferezin PC; Marone MM
    Gynecol Endocrinol; 2005 Nov; 21(5):295-301. PubMed ID: 16373250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.